Tonix Pharmaceuticals Holding (TNXP) Financials

$12.83

$-0.33 (-2.51%)

As on 09-Sep-2026 16:00EDT

Market cap

$225 Mln

Revenue (TTM)

$29 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	29.10	13.11	10.09	7.77	9.03	--
Cost of Revenue	5.75	8.57	7.77	4.74	112.09	92.31
Gross Profit	23.35	4.54	2.33	3.03	-112.09	-92.31
Operating Expenses	188.78	130.25	139.03	121.41	112.09	92.31
Operating Profit (EBIT)	-165.43	-125.70	-136.70	-118.38	-112.09	-92.31
Other Income	--	--	--	--	--	0.03
Profit before Tax	-159.67	-124.02	-130.04	-116.66	-110.22	-92.29
Provision for Tax	--	--	-1.17	0.00	4.79	-0.08
Profit after Tax (Net Income)	-159.67	-124.02	-130.04	-116.66	-115.00	-92.21
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-116.88	-92.29

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	222.28	245.15	139.56	105.53	207.18	218.72
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.02	1.18	5.03	30.05	0.33	0.47
Current Liabilities	30.79	30.84	18.31	18.88	18.18	21.72
Total Liabilities	284.87	277.17	162.89	154.46	225.69	240.90

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	50.66	48.30	43.89	106.69	94.91	51.85
Current Assets	203.43	228.88	119.00	47.77	130.78	189.05
Total Assets	284.87	277.17	162.89	154.46	225.69	240.90
Total Debt*	1.27	1.31	5.30	9.81	0.76	0.96
Net Current Assets	172.65	198.04	100.70	28.88	112.60	167.33

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-99.84	-60.93	-102.00	-98.05	-75.56
Cash Flow from Investing Activities	--	-4.53	-0.12	-29.07	-48.15	-35.31
Cash from Financing Activities	--	214.53	134.87	36.52	87.84	212.49
Net Cash Inflow / Outflow	--	--	--	--	--	101.62

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-14.47	-14.57	-57.45	-1,166,580.00	-1,150,040.00	-461,060.00
Cash EPS ($)	--	-14.35	-55.94	-1,127,920.00	-1,137,510.00	-460,810.00
Adjusted Book Value ($)	--	28.80	61.66	1,055,250.00	2,071,820.00	1,093,585.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-11.73	-26.92	-1,020,030.00	-980,530.00	-377,785.00
Free Cash Flow per Share ($)	--	-12.13	-26.97	-1,098,980.00	-1,462,000.00	-554,320.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-63.39	-99.95	-72.17	-53.79	-59.76
ROE (%)	-68.32	-64.48	-106.12	-74.61	-54.01	-60.20
ROA (%)	-65.00	-56.37	-81.95	-61.38	-49.30	-54.39
EBIT Margin (%)	-548.64	-945.54	-770.20	-1,501.78	-1,241.73	--
Net Margin (%)	-548.64	-946.22	-1,288.25	-1,501.78	-1,274.00	-368,848.00
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	196.02	0.30	0.30	-0.14	--	-1.00
EBIT Growth (%)	-96.10	-59.41	33.36	-4.07	-21.43	-82.76
Net Profit Growth (%)	-96.10	4.63	-11.47	-1.44	-24.72	-83.00
EPS Growth (%)	99.43	0.75	1.00	-0.01	-1.49	0.08
Book Value Growth (%)	-41.72	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.07	-0.01	--	--	0.00
Price / Book Value	1.03	0.54	0.01	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.94	0.60	1.25	0.13	1.08	1.93
Close Price ($)	12.76	15.62	32.98	1,280.00	7,796.00	228,928.00
High Price ($)	69.97	69.97	1,408.00	31,400.00	272,000.00	1,356,800.00
Low Price ($)	10.06	6.76	11.80	1,152.00	5,780.00	227,712.00
Market Cap ($ Cr)	225.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.04	0.09	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.02	0.00	0.00
Current Ratio	6.61	7.42	6.50	2.53	7.19	8.71
Quick Ratio	6.42	7.23	6.04	1.78	7.64	--
Interest Coverage	-1,793.00	-1,392.49	-63.00	--	-14.17	-1,846.24

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	40.56	74.43	78.30	59.09	89.10	--
Asset Turnover	0.12	0.06	0.06	0.04	0.04	--
Receivable days	--	246.06	226.05	297.00	319.02	--
Inventory Days	--	307.49	530.47	235.13	-26.21	-30.18
Payable days	--	269.94	195.87	456.47	34.78	35.37
Cash Conversion Cycle	--	283.61	560.65	75.66	258.03	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.